MedPath

Prognostic Study of Gastric MALT Lymphoma After Eradication of Helicobacter Pylori

Not Applicable
Conditions
Gastric mucosa-associated lymphoid tissue lymphoma
Registration Number
JPRN-jRCT1080222003
Lead Sponsor
Eisai Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
100
Inclusion Criteria

Gastric low-grade mucosa-associated lymphoid tissue (MALT) lymphoma with Helicobacter pylori positive
The stages of MALT lymphoma are Lugano International Conference classification Stage I or II 1 and Wotherspoon grade 4 or 5

Exclusion Criteria

With diffuse large B-cell lymphoma
Corresponding to contraindication of each drug
Have been treated to gastric mucosa-associated lymphoid tissue (MALT) lymphoma

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Response rate of gastric low-grade MALT lymphoma by eradication of Helicobacter pylori <br>Transition rate to secondary therapy for eradication of Helicobacter pylori
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath